H Bekki1, T Duffy1, N Okubo1, M Olmer1, O Alvarez-Garcia1, K Lamia1, S Kay2, M Lotz3. 1. Department of Molecular Medicine, Scripps Research, La Jolla, CA, USA. 2. Keck School of Medicine, University of Southern California, Los Angeles, CA, 90089, USA. 3. Department of Molecular Medicine, Scripps Research, La Jolla, CA, USA. Electronic address: mlotz@scripps.edu.
Abstract
OBJECTIVES: Abnormal chondrocyte gene expression promotes osteoarthritis (OA) pathogenesis. A previous RNA-sequencing study revealed that circadian rhythm pathway and expression of core clock gene cryptochrome 2 (CRY2) are dysregulated in human OA cartilage. Here we determined expression patterns and function CRY1 and CRY2. METHODS: CRY mRNA and protein expression was analyzed in normal and OA human and mouse cartilage. Mice with deletion of Cry1 or Cry2 were analyzed for severity of experimental OA and to determine genes and pathways that are regulated by Cry. RESULTS: In human OA cartilage, CRY2 but not CRY1 staining and mRNA expression was significantly decreased. Cry2 was also suppressed in mice with aging-related OA. Cry2 knock out (KO) but not Cry1 KO mice with experimental OA showed significantly increased severity of histopathological changes in cartilage, subchondral bone and synovium. In OA chondrocytes, the levels of CRY1 and CRY2 and the amplitude of circadian fluctuation were significantly lower. RNA-seq on knee articular cartilage of wild-type and Cry2 KO mice identified 53 differentially expressed genes, including known Cry2 target circadian genes Nr1d1, Nr1d2, Dbp and Tef. Pathway analysis that circadian rhythm and extracellular matrix remodeling were dysregulated in Cry2 KO mice. CONCLUSIONS: These results show an active role of the circadian clock in general, and of CRY2 in particular, in maintaining extracellular matrix (ECM) homeostasis in cartilage. This cell autonomous network of circadian rhythm genes is disrupted in OA chondrocytes. Targeting CRY2 has potential to correct abnormal gene expression patterns and reduce the severity of OA.
OBJECTIVES: Abnormal chondrocyte gene expression promotes osteoarthritis (OA) pathogenesis. A previous RNA-sequencing study revealed that circadian rhythm pathway and expression of core clock gene cryptochrome 2 (CRY2) are dysregulated in human OA cartilage. Here we determined expression patterns and function CRY1 and CRY2. METHODS: CRY mRNA and protein expression was analyzed in normal and OA human and mouse cartilage. Mice with deletion of Cry1 or Cry2 were analyzed for severity of experimental OA and to determine genes and pathways that are regulated by Cry. RESULTS: In human OA cartilage, CRY2 but not CRY1 staining and mRNA expression was significantly decreased. Cry2 was also suppressed in mice with aging-related OA. Cry2 knock out (KO) but not Cry1 KO mice with experimental OA showed significantly increased severity of histopathological changes in cartilage, subchondral bone and synovium. In OA chondrocytes, the levels of CRY1 and CRY2 and the amplitude of circadian fluctuation were significantly lower. RNA-seq on knee articular cartilage of wild-type and Cry2 KO mice identified 53 differentially expressed genes, including known Cry2 target circadian genes Nr1d1, Nr1d2, Dbp and Tef. Pathway analysis that circadian rhythm and extracellular matrix remodeling were dysregulated in Cry2 KO mice. CONCLUSIONS: These results show an active role of the circadian clock in general, and of CRY2 in particular, in maintaining extracellular matrix (ECM) homeostasis in cartilage. This cell autonomous network of circadian rhythm genes is disrupted in OA chondrocytes. Targeting CRY2 has potential to correct abnormal gene expression patterns and reduce the severity of OA.
Authors: A Balsalobre; S A Brown; L Marcacci; F Tronche; C Kellendonk; H M Reichardt; G Schütz; U Schibler Journal: Science Date: 2000-09-29 Impact factor: 47.728
Authors: G T van der Horst; M Muijtjens; K Kobayashi; R Takano; S Kanno; M Takao; J de Wit; A Verkerk; A P Eker; D van Leenen; R Buijs; D Bootsma; J H Hoeijmakers; A Yasui Journal: Nature Date: 1999-04-15 Impact factor: 49.962
Authors: Maureen K Bunger; Jacqueline A Walisser; Ruth Sullivan; Paul A Manley; Susan M Moran; Vicki L Kalscheur; Ricki J Colman; Christopher A Bradfield Journal: Genesis Date: 2005-03 Impact factor: 2.487
Authors: Sven Heinz; Christopher Benner; Nathanael Spann; Eric Bertolino; Yin C Lin; Peter Laslo; Jason X Cheng; Cornelis Murre; Harinder Singh; Christopher K Glass Journal: Mol Cell Date: 2010-05-28 Impact factor: 17.970
Authors: K M Fisch; R Gamini; O Alvarez-Garcia; R Akagi; M Saito; Y Muramatsu; T Sasho; J A Koziol; A I Su; M K Lotz Journal: Osteoarthritis Cartilage Date: 2018-08-03 Impact factor: 6.576
Authors: Trey K Sato; Rikuhiro G Yamada; Hideki Ukai; Julie E Baggs; Loren J Miraglia; Tetsuya J Kobayashi; David K Welsh; Steve A Kay; Hiroki R Ueda; John B Hogenesch Journal: Nat Genet Date: 2006-02-12 Impact factor: 38.330
Authors: Mark A Naven; Leo A H Zeef; Shiyang Li; Paul A Humphreys; Christopher A Smith; Dharshika Pathiranage; Stuart Cain; Steven Woods; Nicola Bates; Manting Au; Chunyi Wen; Susan J Kimber; Qing-Jun Meng Journal: Theranostics Date: 2022-05-13 Impact factor: 11.600
Authors: Lara Pferdehirt; Anna R Damato; Michal Dudek; Qing-Jun Meng; Erik D Herzog; Farshid Guilak Journal: Sci Adv Date: 2022-05-25 Impact factor: 14.957